BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19578996)

  • 1. Sjögren syndrome or sjögren disease? The histological and immunological bias caused by the 2002 criteria.
    Ramos-Casals M; Brito-Zerón P; Perez-De-Lis M; Jimenez I; Blanco MJ; Bove A; Soto MJ; Akasbi M; Diaz C; Sentís J; Siso A
    Clin Rev Allergy Immunol; 2010 Apr; 38(2-3):178-85. PubMed ID: 19578996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of IgA Anti-α-fodrin Antibodies in Combination with Rheumatoid Factor and/or Antinuclear Antibodies as Substitute Immunological Criterion in Sjögren Syndrome with Negative Anti-SSA/SSB Antibodies.
    Hernández-Molina G; Nuñez-Alvarez C; Avila-Casado C; Llorente L; Hernández-Hernández C; Calderillo ML; Marroquín V; Recillas-Gispert C; Romero-Díaz J; Sánchez-Guerrero J
    J Rheumatol; 2016 Oct; 43(10):1852-1857. PubMed ID: 27481899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome.
    Retamozo S; Akasbi M; Brito-Zerón P; Bosch X; Bove A; Perez-de-Lis M; Jimenez I; Soto-Cardenas MJ; Gandia M; Diaz-Lagares C; Viñas O; Siso A; Perez-Alvarez R; Yague J; Ramos-Casals M
    Clin Exp Rheumatol; 2012; 30(5):686-92. PubMed ID: 22704838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-fodrin autoantibodies are reliable diagnostic markers for juvenile and adult Sjogren's syndrome.
    Lawind MF; Alyasky A; Elwan NM; Mourad H; Al-Bendary A
    Egypt J Immunol; 2004; 11(1):75-81. PubMed ID: 15724389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and serological characteristics of anti-Ro/SS-A and anti-La/SS-B negative primary Sjögren's syndrome: a comparative study.
    Bodakçi E
    Eur Rev Med Pharmacol Sci; 2024 Mar; 28(5):1760-1767. PubMed ID: 38497858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subgroups of Sjögren syndrome patients according to serological profiles.
    Bournia VK; Vlachoyiannopoulos PG
    J Autoimmun; 2012 Aug; 39(1-2):15-26. PubMed ID: 22575069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of antibodies and minor salivary gland biopsy in the study of sicca syndrome in daily clinical practice.
    Santiago ML; Seisdedos MR; Garcia Salinas RN; Catalán Pellet A; Villalón L; Secco A
    Reumatol Clin; 2015; 11(3):156-60. PubMed ID: 25579246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sjögren syndrome associated with hepatitis C virus: a multicenter analysis of 137 cases.
    Ramos-Casals M; Loustaud-Ratti V; De Vita S; Zeher M; Bosch JA; Toussirot E; Medina F; Rosas J; Anaya JM; Font J;
    Medicine (Baltimore); 2005 Mar; 84(2):81-89. PubMed ID: 15758837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: analysis of 10,500 patients (Sjögren Big Data Project).
    Brito-Zerón P; Acar-Denizli N; Ng WF; Zeher M; Rasmussen A; Mandl T; Seror R; Li X; Baldini C; Gottenberg JE; Danda D; Quartuccio L; Priori R; Hernandez-Molina G; Armagan B; Kruize AA; Kwok SK; Kvarnström M; Praprotnik S; Sène D; Bartoloni E; Solans R; Rischmueller M; Suzuki Y; Isenberg DA; Valim V; Wiland P; Nordmark G; Fraile G; Bootsma H; Nakamura T; Giacomelli R; Devauchelle-Pensec V; Knopf A; Bombardieri M; Trevisani VF; Hammenfors D; Pasoto SG; Retamozo S; Gheita TA; Atzeni F; Morel J; Vollenveider C; Horvath IF; Sivils KL; Olsson P; De Vita S; Sánchez-Guerrero J; Kilic L; Wahren-Herlenius M; Mariette X; Ramos-Casals M;
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):102-112. PubMed ID: 30156539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
    Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
    Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical manifestations correlated to the prevalence of autoantibodies in a large (n=321) cohort of patients with primary Sjögren's syndrome: a comparison of patients initially diagnosed according to the Copenhagen classification criteria with the American-European consensus criteria.
    Locht H; Pelck R; Manthorpe R
    Autoimmun Rev; 2005 Jun; 4(5):276-81. PubMed ID: 15990074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is extra-glandular organ damage in primary Sjögren's syndrome related to the presence of systemic auto-antibodies and/or hypergammaglobulinemia? A long-term cohort study with 110 patients from the Netherlands.
    Ter Borg EJ; Kelder JC
    Int J Rheum Dis; 2017 Jul; 20(7):875-881. PubMed ID: 28447402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of Sjögren's Syndrome Years Before Diagnosis and Identification of Patients With Early Onset and Severe Disease Course by Autoantibody Profiling.
    Theander E; Jonsson R; Sjöström B; Brokstad K; Olsson P; Henriksson G
    Arthritis Rheumatol; 2015 Sep; 67(9):2427-36. PubMed ID: 26109563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How hepatitis C virus modifies the immunological profile of Sjögren syndrome: analysis of 783 patients.
    Brito-Zerón P; Gheitasi H; Retamozo S; Bové A; Londoño M; Sánchez-Tapias JM; Caballero M; Kostov B; Forns X; Kaveri SV; Ramos-Casals M
    Arthritis Res Ther; 2015 Sep; 17(1):250. PubMed ID: 26370711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sjögren's syndrome: association of anti-Ro(SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity.
    Alexander EL; Arnett FC; Provost TT; Stevens MB
    Ann Intern Med; 1983 Feb; 98(2):155-9. PubMed ID: 6600593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary Sjögren syndrome in Spain: clinical and immunologic expression in 1010 patients.
    Ramos-Casals M; Solans R; Rosas J; Camps MT; Gil A; Del Pino-Montes J; Calvo-Alen J; Jiménez-Alonso J; Micó ML; Beltrán J; Belenguer R; Pallarés L;
    Medicine (Baltimore); 2008 Jul; 87(4):210-219. PubMed ID: 18626304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similarities and differences between primary and secondary Sjögren's syndrome.
    Hernández-Molina G; Avila-Casado C; Cárdenas-Velázquez F; Hernández-Hernández C; Calderillo ML; Marroquín V; Soto-Abraham V; Recillas-Gispert C; Sánchez-Guerrero J
    J Rheumatol; 2010 Apr; 37(4):800-8. PubMed ID: 20194453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjögren's syndrome?
    Manthorpe R; Benoni C; Jacobsson L; Kirtava Z; Larsson A; Liedholm R; Nyhagen C; Tabery H; Theander E
    Ann Rheum Dis; 2000 Jan; 59(1):54-60. PubMed ID: 10627428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting Sjögren's syndrome in patients with recent-onset SLE.
    Hernández-Molina G; Zamora-Legoff T; Romero-Díaz J; Nuñez-Alvarez CA; Cárdenas-Velázquez F; Hernández-Hernández C; Calderillo ML; Marroquín M; Recillas-Gispert C; Ávila-Casado C; Sánchez-Guerrero J
    Rheumatology (Oxford); 2013 Aug; 52(8):1438-42. PubMed ID: 23594470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sjögren Syndrome without Focal Lymphocytic Infiltration of the Salivary Glands.
    Sharma R; Chaudhari KS; Kurien BT; Grundahl K; Radfar L; Lewis DM; Lessard CJ; Li H; Rasmussen A; Sivils KL; Scofield RH
    J Rheumatol; 2020 Mar; 47(3):394-399. PubMed ID: 31092717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.